Physician

Aditya Kanesa-Thasan, M.D.

According to 2025 Medicare claims, Aditya Kanesa-Thasan, M.D. (NPI: 1700276391) practices ophthalmology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Chester, PA. This provider's primary affiliated billing organization is WILLS EYE OPHTHALMOLOGY CLINIC, INC (NPI: 1184624009; TIN: 233065896) and primary practice location at 19301-1759.

Kanesa-Thasan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 875 traditional Medicare patients, billed 2,446 HCPCS/CPT codes, and received $237,042 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,885 prescription claims across 458 beneficiaries totaling $614,261 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 15 records totaling $731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,823 to $237,042. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,231 to $614,261. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$119K$238K2019 Medicare payment: $5,823 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $32,826 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $101,041 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $158,306 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $237,987 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $237,042 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019108143$5,823
2020172366$32,826
20213431,018$101,041
20225631,693$158,306
20238152,317$237,987
20248752,446$237,042

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$307K$614K2015 Drug cost: $1,231 (USD; Tot_Drug_Cst)2016 Drug cost: $29,539 (USD; Tot_Drug_Cst)2017 Drug cost: $40,184 (USD; Tot_Drug_Cst)2018 Drug cost: $39,069 (USD; Tot_Drug_Cst)2019 Drug cost: $41,318 (USD; Tot_Drug_Cst)2020 Drug cost: $57,812 (USD; Tot_Drug_Cst)2021 Drug cost: $385,184 (USD; Tot_Drug_Cst)2022 Drug cost: $385,258 (USD; Tot_Drug_Cst)2023 Drug cost: $390,944 (USD; Tot_Drug_Cst)2024 Drug cost: $614,261 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151327$1,231
201689236$29,539
2017210637$40,184
2018210834$39,069
2019238747$41,318
2020180499$57,812
2021193676$385,184
20222621,004$385,258
20233641,470$390,944
20244581,885$614,261

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more373719$98
92014Established patient complete exam of visual system229256$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more346407$68
92134Imaging of retina116134$31
92136Measurement of corneal curvature and depth of eye159201$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine965,925$117,716
MieboPerfluorohexyloctane/Pf772,635$67,735
CyclosporineCyclosporine805,535$46,589
LumiganBimatoprost603,573$34,028
Prednisolone AcetatePrednisolone Acetate23710,813$11,338

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$731Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aditya Kanesa-Thasan, M.D.?

Tedicare shows public-source Medicare data for Aditya Kanesa-Thasan, M.D. (NPI 1700276391), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aditya Kanesa-Thasan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aditya Kanesa-Thasan, M.D.?

Aditya Kanesa-Thasan, M.D. is linked to WILLS EYE OPHTHALMOLOGY CLINIC, INC (billing NPI 1184624009) in the available physician profile data.

Does Aditya Kanesa-Thasan, M.D. have Open Payments data?

Aditya Kanesa-Thasan, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.